Anna Malm Bernsten runs a consultancy business in the area of international business development, strategy, management and brand management issues. Anna has long and in-depth experience of Life Science including as President and CEO at Carmeda AB, as well as having held senior positions at Pharmacia, ASSA ABLOY AB and GE Healthcare. She has extensive experience of Board work, including as Chairman of the Board of Medivir and Board member of Cellavision AB, Arcam AB and Neurovive AB. Up until year-end 2016, Anna was Chairman of Oatly AB. She has a Masters degree in chemical engineering from the Royal Institute of Technology in Stockholm.